⌘K

Login Start Free

Home/Filings/4/0001415889-25-006037

4//SEC Filing

Raymon Heather 4

Accession 0001415889-25-006037

CIK 0001817241other

View on SEC.gov Company Profile

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 5:15 PM ET

Size

4.8 KB

Accession

0001415889-25-006037

Insider Transaction Report

Form 4

Period: 2025-02-26

Artiva Biotherapeutics, Inc.ARTV

SVP, Research and Development

Transactions

Award
Common Stock
2025-02-26+33,350→ 43,350 total

Footnotes (1)

[F1]Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan.

Documents

1 file

4
form4-02282025_050211.xmlPrimary

Issuer

Artiva Biotherapeutics, Inc.

CIK 0001817241

Entity typeother

Related Parties

1

filerCIK 0002028466

Filing Metadata

Form type: 4
Filed: Feb 27, 7:00 PM ET
Accepted: Feb 28, 5:15 PM ET
Size: 4.8 KB

View on SEC.gov